Handelsbanken Fonder’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.4M | Buy |
214,293
+6,648
| +3% | +$2.96M | 0.34% | 62 |
|
|
2025
Q1 | $101M | Sell |
207,645
-88,391
| -30% | -$42.9M | 0.42% | 45 |
|
|
2024
Q4 | $119M | Sell |
296,036
-115,479
| -28% | -$46.5M | 0.46% | 37 |
|
|
2024
Q3 | $191M | Sell |
411,515
-4,866
| -1% | -$2.26M | 0.76% | 19 |
|
|
2024
Q2 | $195M | Buy |
416,381
+145,696
| +54% | +$68.3M | 0.85% | 16 |
|
|
2024
Q1 | $113M | Buy |
270,685
+10,412
| +4% | +$4.35M | 0.49% | 32 |
|
|
2023
Q4 | $106M | Sell |
260,273
-21,880
| -8% | -$8.9M | 0.51% | 32 |
|
|
2023
Q3 | $98.1M | Sell |
282,153
-3,780
| -1% | -$1.31M | 0.55% | 32 |
|
|
2023
Q2 | $101M | Sell |
285,933
-49,918
| -15% | -$17.6M | 0.54% | 32 |
|
|
2023
Q1 | $106M | Buy |
335,851
+5,090
| +2% | +$1.6M | 0.61% | 29 |
|
|
2022
Q4 | $95.5M | Sell |
330,761
-26,056
| -7% | -$7.52M | 0.6% | 31 |
|
|
2022
Q3 | $103M | Buy |
356,817
+6,361
| +2% | +$1.84M | 0.69% | 24 |
|
|
2022
Q2 | $98.8M | Buy |
350,456
+142,575
| +69% | +$40.2M | 0.64% | 25 |
|
|
2022
Q1 | $54.3M | Buy |
207,881
+13,837
| +7% | +$3.61M | 0.3% | 70 |
|
|
2021
Q4 | $42.6M | Buy |
194,044
+121,656
| +168% | +$26.7M | 0.21% | 110 |
|
|
2021
Q3 | $13.1M | Sell |
72,388
-39,633
| -35% | -$7.19M | 0.07% | 273 |
|
|
2021
Q2 | $22.6M | Sell |
112,021
-94,556
| -46% | -$19.1M | 0.12% | 184 |
|
|
2021
Q1 | $44.4M | Buy |
206,577
+3,571
| +2% | +$767K | 0.25% | 89 |
|
|
2020
Q4 | $48M | Buy |
203,006
+25,944
| +15% | +$6.13M | 0.29% | 87 |
|
|
2020
Q3 | $48.2M | Sell |
177,062
-6,020
| -3% | -$1.64M | 0.35% | 65 |
|
|
2020
Q2 | $53.2M | Buy |
183,082
+55,374
| +43% | +$16.1M | 0.45% | 49 |
|
|
2020
Q1 | $30.4M | Sell |
127,708
-10,000
| -7% | -$2.38M | 0.65% | 46 |
|
|
2019
Q4 | $30.2M | Buy |
137,708
+21,708
| +19% | +$4.75M | 0.52% | 63 |
|
|
2019
Q3 | $19.7M | Buy |
116,000
+15,000
| +15% | +$2.54M | 0.4% | 74 |
|
|
2019
Q2 | $18.5M | Buy |
101,000
+27,000
| +36% | +$4.95M | 0.34% | 81 |
|
|
2019
Q1 | $13.6M | Sell |
74,000
-15,000
| -17% | -$2.76M | 0.26% | 95 |
|
|
2018
Q4 | $14.7M | Buy |
89,000
+8,000
| +10% | +$1.33M | 0.3% | 91 |
|
|
2018
Q3 | $15.6M | Buy |
81,000
+24,000
| +42% | +$4.63M | 0.29% | 97 |
|
|
2018
Q2 | $9.69M | Buy |
57,000
+15,000
| +36% | +$2.55M | 0.19% | 123 |
|
|
2018
Q1 | $6.85M | Buy |
42,000
+8,500
| +25% | +$1.39M | 0.13% | 134 |
|
|
2017
Q4 | $5.02M | Buy |
33,500
+14,500
| +76% | +$2.17M | 0.11% | 135 |
|
|
2017
Q3 | $2.89M | Buy |
+19,000
| New | +$2.89M | 0.07% | 152 |
|
|
2016
Q1 | – | Sell |
-24,618
| Closed | -$3.1M | – | 580 |
|
|
2015
Q4 | $3.1M | Buy |
+24,618
| New | +$3.1M | 0.06% | 263 |
|